Structures by: Franzblau S. G.
Total: 10
2(C54H77N9O9),3(O)
2(C54H77N9O9),3(O)
Journal of natural products (2020)
a=13.9590(10)Å b=25.347(2)Å c=18.606(2)Å
α=90° β=109.574(2)° γ=90°
Dihydroparthenolide diol
C15H24O5
Acta Crystallographica Section E (2001) 57, 4 o323-o325
a=9.2706(13)Å b=10.4565(8)Å c=15.094(3)Å
α=90° β=90° γ=90°
?
C18H14Cl1F3N2O2
Journal of Organic Chemistry (2009) 74, 5297-5303
a=15.9749(2)Å b=16.4925(3)Å c=27.4117(6)Å
α=81.5285(7)° β=82.2566(7)° γ=89.0766(14)°
C27H35BrO3
C27H35BrO3
Journal of Organic Chemistry (2007) 72, 7343-7351
a=11.3840(13)Å b=10.6382(12)Å c=20.331(2)Å
α=90.00° β=90.589(2)° γ=90.00°
N-Benzyl-3,7-dimethylimidazo[1,2-a]pyridine-2-carboxamide
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=7.9379(3)Å b=19.6844(9)Å c=9.5568(4)Å
α=90.° β=100.934(2)° γ=90.°
N-Benzyl-7-methyl-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide
C15H14N4O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=9.772(3)Å b=5.8461(19)Å c=22.078(7)Å
α=90.° β=91.411(6)° γ=90.°
N-Benzyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
C15H15N5O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=20.3189(11)Å b=10.8268(5)Å c=15.6023(9)Å
α=90.° β=129.107(3)° γ=90.°
N-Benzyl-6-methyl-2H-indazole-3-carboxamide
C16H15N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=5.9164(2)Å b=13.0740(3)Å c=18.5711(5)Å
α=109.4990(10)° β=93.229(2)° γ=94.402(2)°
N-Benzyl-2,6-dimethylimidazo[1,2-b]pyridazine-3-carboxamide
C16H16N4O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=9.3005(8)Å b=6.6121(5)Å c=11.8267(10)Å
α=90.° β=106.2760(10)° γ=90.°
N-Benzyl-2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide (1)
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=4.8686(4)Å b=15.1351(13)Å c=19.0283(18)Å
α=94.372(5)° β=93.841(6)° γ=93.639(5)°